NEW YORK, Dec. 19, 2025 /PRNewswire/ — Medome is the first AI technology for Personal Health Records for consumers. Patented and clinically validated with thousandsNEW YORK, Dec. 19, 2025 /PRNewswire/ — Medome is the first AI technology for Personal Health Records for consumers. Patented and clinically validated with thousands

Medome Launch Heralds the End of Medical Misdiagnoses and Lost Lives

NEW YORK, Dec. 19, 2025 /PRNewswire/ — Medome is the first AI technology for Personal Health Records for consumers. Patented and clinically validated with thousands of real patients, it represents a groundbreaking approach to medical diagnostics, officially launching today to prevent misdiagnoses and improve patient outcomes. Created by physicians and technologists who have personally experienced the consequences of medical errors, Medome leverages advanced AI to bridge the gap between patients and the accurate healthcare they crave.

Medome arose from a tragic loss. Dr. Steven Charlap, a physician and entrepreneur, lost his brother to a preventable cancer medical diagnosis error. These preventable events underscore a devastating reality: nearly 400,000 people in the U.S. die each year due to errors in the diagnostic processes.

Driven by these experiences, the Medome team has harnessed the potential of AI to change the course of patient safety. “Medome exists so no one else dies again from misdiagnosis,” Dr. Charlap says, emphasizing that this platform was built to save lives through superior medical diagnostics.

Medome is not just another patient-facing symptom checker or a basic ai doctor; it is a comprehensive ai doctor diagnosis system. By utilizing sophisticated AI systems to organize, synthesize, and analyze personal information from lab results to family history Medome portrays a complete picture, uncovering patterns that often get missed.

Unlike other tools, Medome performs multiple intense calibrations in real time to narrow down possibilities. Dr. Charlap explains, “Medical knowledge now exceeds human intellectual capabilities. Our goal is not to replace human doctors but to enable patients to assist clinicians by being more contributory to their health journeys.” By using artificial intelligence as the bridge, the platform enhances decisions and identifies safety issues early when they are most effectively treated.

Medome represents a paradigm shift where enabled patients work alongside their providers. By applying proprietary methodologies to complex data, Medome which received support from Stanford, Harvard, the NIH, and the UK’s National Health Services enables patients to exert greater control over their diagnosis and treatment plan.

“We built Medome to save lives and ensure no one has to encounter a physician alone again,” Dr. Charlap concludes.

About Medome

Medome is an ai medical diagnosis and health intelligence platform that consolidates your medical history to provide a personalized treatment plan and prevent crises. It analyzes symptoms against your unique risk profile and distinguishes a local emergency from manageable problems. When you do need urgent care, it instantly generates a comprehensive medical summary to optimize diagnostic processes. Think of it as a medical command center that knows you better than any 15-minute appointment ever could.

Users can learn more at: www.medome.ai

Contact
Medome
media@medome.ai

Photo – https://mma.prnewswire.com/media/2849829/Medome_Logo.jpg

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/medome-launch-heralds-the-end-of-medical-misdiagnoses-and-lost-lives-302647184.html

SOURCE Medome

Market Opportunity
Sleepless AI Logo
Sleepless AI Price(AI)
$0.03643
$0.03643$0.03643
+2.07%
USD
Sleepless AI (AI) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

ArtGis Finance Partners with MetaXR to Expand its DeFi Offerings in the Metaverse

ArtGis Finance Partners with MetaXR to Expand its DeFi Offerings in the Metaverse

By using this collaboration, ArtGis utilizes MetaXR’s infrastructure to widen access to its assets and enable its customers to interact with the metaverse.
Share
Blockchainreporter2025/09/18 00:07
MAXI DOGE Holders Diversify into $GGs for Fast-Growth 2025 Crypto Presale Opportunities

MAXI DOGE Holders Diversify into $GGs for Fast-Growth 2025 Crypto Presale Opportunities

Presale crypto tokens have become some of the most active areas in Web3, offering early access to projects that blend culture, finance, and technology. Investors are constantly searching for the best crypto presale to buy right now, comparing new token presales across different niches. MAXI DOGE has gained attention for its meme-driven energy, but early [...] The post MAXI DOGE Holders Diversify into $GGs for Fast-Growth 2025 Crypto Presale Opportunities appeared first on Blockonomi.
Share
Blockonomi2025/09/18 00:00
Edges higher ahead of BoC-Fed policy outcome

Edges higher ahead of BoC-Fed policy outcome

The post Edges higher ahead of BoC-Fed policy outcome appeared on BitcoinEthereumNews.com. USD/CAD gains marginally to near 1.3760 ahead of monetary policy announcements by the Fed and the BoC. Both the Fed and the BoC are expected to lower interest rates. USD/CAD forms a Head and Shoulder chart pattern. The USD/CAD pair ticks up to near 1.3760 during the late European session on Wednesday. The Loonie pair gains marginally ahead of monetary policy outcomes by the Bank of Canada (BoC) and the Federal Reserve (Fed) during New York trading hours. Both the BoC and the Fed are expected to cut interest rates amid mounting labor market conditions in their respective economies. Inflationary pressures in the Canadian economy have cooled down, emerging as another reason behind the BoC’s dovish expectations. However, the Fed is expected to start the monetary-easing campaign despite the United States (US) inflation remaining higher. Investors will closely monitor press conferences from both Fed Chair Jerome Powell and BoC Governor Tiff Macklem to get cues about whether there will be more interest rate cuts in the remainder of the year. According to analysts from Barclays, the Fed’s latest median projections for interest rates are likely to call for three interest rate cuts by 2025. Ahead of the Fed’s monetary policy, the US Dollar Index (DXY), which tracks the Greenback’s value against six major currencies, holds onto Tuesday’s losses near 96.60. USD/CAD forms a Head and Shoulder chart pattern, which indicates a bearish reversal. The neckline of the above-mentioned chart pattern is plotted near 1.3715. The near-term trend of the pair remains bearish as it stays below the 20-day Exponential Moving Average (EMA), which trades around 1.3800. The 14-day Relative Strength Index (RSI) slides to near 40.00. A fresh bearish momentum would emerge if the RSI falls below that level. Going forward, the asset could slide towards the round level of…
Share
BitcoinEthereumNews2025/09/18 01:23